(25) reported that AS-1, an inhibitor of RAGE signalling, suppressed the proliferation of smooth muscle cells of patients with idiopathic and heritable PAH, showing that inhibition of RAGE signalling may be a new therapeutic target for PAH. Here, AGER is linked to pulmonary arterial hypertension.